Deep Track Capital, LP

Investment Portfolio & 13F Holdings Analysis

About

Deep Track Capital, LP is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 69 holdings worth $3.1 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 69
Total Value: 3088173822
Accession Number: 0001856083-25-000002
Form Type: 13F-HR
CIK: 0001856083
Manager Name: Deep Track Capital, LP

Data Enrichment

93% identified

64 identified5 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

69 positions • $3,088,173.822K total value

69 positions

Manager:

SEC FilingSEC DataHachi Filing

Search and click to pin securities to the top

Page 1 of 4

Sort by:

46116X101

2000000(+0.0%)

Value:

$263.8B(+58.0%)

Guardant Health, Inc.

GH|40131M109

5443721(-15.2%)

Value:

$231.9B(+18.2%)

DYNAVAX TECHNOLOGIES CORP

DVAX|268158201

17791486(+0.0%)

Value:

$230.8B(+1.6%)

Immunovant, Inc.

IMVT|45258J102

9500000(+58.3%)

Value:

$162.4B(+9.2%)

Protagonist Therapeutics, Inc

PTGX|74366E102

3000000(+200.0%)

Value:

$145.1B(+275.9%)

IONIS PHARMACEUTICALS INC

IONS|462222100

4564207(+136.0%)

Value:

$137.7B(+103.7%)

Akero Therapeutics, Inc.

AKRO|00973Y108

3210270(+115.5%)

Value:

$130.0B(+213.5%)

CYTOKINETICS INC

CYTK|23282W605

3073853(+22.9%)

Value:

$123.5B(+5.0%)

Apellis Pharmaceuticals, Inc.

APLS|03753U106

5000000(+17.0%)

Value:

$109.3B(-19.8%)

OCULAR THERAPEUTIX, INC

OCUL|67576A100

14294420(+11.3%)

Value:

$104.8B(-4.4%)

BridgeBio Pharma, Inc.

BBIO|10806X102

2800000(+241.8%)

Value:

$96.8B(+330.6%)

Tarsus Pharmaceuticals, Inc.

TARS|87650L103

1484266

Value:

$76.2B

Viridian Therapeutics, Inc.\DE

VRDN|92790C104

5380449(+19.0%)

Value:

$72.5B(-16.3%)

Structure Therapeutics Inc.

GPCR|86366E106

4100000(+46.4%)

Value:

$71.0B(-6.5%)

89bio, Inc.

ETNB|282559103

9316333(+43.8%)

Value:

$67.7B(+33.7%)

Nurix Therapeutics, Inc.

NRIX|67080M103

5500000(+83.3%)

Value:

$65.3B(+15.6%)

GERON CORP

GERN|374163103

38176251(+851.7%)

Value:

$60.7B(+327.5%)

Sarepta Therapeutics, Inc.

SRPT|803607100

899731

Value:

$57.4B

Ultragenyx Pharmaceutical Inc.

RARE|90400D108

1350000(+106.6%)

Value:

$48.9B(+77.8%)

ANI PHARMACEUTICALS INC

ANIP|00182C103

700000(+7.8%)

Value:

$46.9B(+30.6%)

Instrument	Shares		Other Manager	Value
(cusip46116X101)✕	2.0M	QoQ 0.00% (+0) YoY +33.33% (+500.0K)	All Managers (Combined)	$263.8M	QoQ +57.95% (+$96.8M) YoY +154.18% (+$160.0M)
Guardant Health, Inc.(GHcusip40131M109)	5.4M	QoQ -15.20% (-975.8K) YoY -9.27% (-556.3K)	All Managers (Combined)	$231.9M	QoQ +18.24% (-$35.8M) YoY +87.35% (-$108.1M)
Dynavax Technologies Corp(DVAXcusip268158201)	17.8M	QoQ 0.00% (+0) YoY +94.61% (+8.6M)	All Managers (Combined)	$230.8M	QoQ +1.56% (+$3.6M) YoY +103.40% (+$117.3M)
Immunovant, Inc.(IMVTcusip45258J102)	9.5M	QoQ +58.33% (+3.5M) YoY +1825.60% (+9.0M)	All Managers (Combined)	$162.4M	QoQ +9.24% (+$13.7M) YoY +918.52% (+$146.4M)
Protagonist Therapeutics, Inc(PTGXcusip74366E102)	3.0M	QoQ +200.00% (+2.0M) YoY NEW(+3.0M)	All Managers (Combined)	$145.1M	QoQ +275.85% (+$106.5M) YoY NEW(+$145.1M)
Ionis Pharmaceuticals Inc(IONScusip462222100)	4.6M	QoQ +136.00% (+2.6M) YoY +232.31% (+3.2M)	All Managers (Combined)	$137.7M	QoQ +103.67% (+$70.1M) YoY +131.27% (+$78.2M)
Akero Therapeutics, Inc.(AKROcusip00973Y108)	3.2M	QoQ +115.45% (+1.7M) YoY NEW(+3.2M)	All Managers (Combined)	$130.0M	QoQ +213.50% (+$88.5M) YoY NEW(+$130.0M)
Cytokinetics Inc(CYTKcusip23282W605)	3.1M	QoQ +22.95% (+573.9K) YoY NEW(+3.1M)	All Managers (Combined)	$123.5M	QoQ +5.04% (+$5.9M) YoY NEW(+$123.5M)
Apellis Pharmaceuticals, Inc.(APLScusip03753U106)	5.0M	QoQ +16.96% (-725.1K) YoY +400.00% (+4.0M)	All Managers (Combined)	$109.3M	QoQ -19.83% (-$27.1M) YoY +86.03% (+$50.6M)
Ocular Therapeutix, Inc(OCULcusip67576A100)	14.3M	QoQ +11.35% (-1.5M) YoY +12.36% (-1.6M)	All Managers (Combined)	$104.8M	QoQ -4.41% (-$4.8M) YoY -9.49% (-$11.0M)
Bridgebio Pharma, Inc.(BBIOcusip10806X102)	2.8M	QoQ +241.81% (+2.0M) YoY NEW(+2.8M)	All Managers (Combined)	$96.8M	QoQ +330.62% (+$74.3M) YoY NEW(+$96.8M)
Tarsus Pharmaceuticals, Inc.(TARScusip87650L103)	1.5M	QoQ NEW(+1.5M) YoY NEW(+1.5M)	All Managers (Combined)	$76.2M	QoQ NEW(+$76.2M) YoY NEW(+$76.2M)
Viridian Therapeutics, Inc.\De(VRDNcusip92790C104)	5.4M	QoQ +18.96% (-857.7K) YoY +55.68% (+1.9M)	All Managers (Combined)	$72.5M	QoQ -16.34% (-$14.2M) YoY +19.85% (+$12.0M)
Structure Therapeutics Inc.(GPCRcusip86366E106)	4.1M	QoQ +46.42% (-1.3M) YoY +10115.01% (+4.1M)	All Managers (Combined)	$71.0M	QoQ -6.53% (-$5.0M) YoY +4025.56% (+$69.3M)
89bio, Inc.(ETNBcusip282559103)	9.3M	QoQ +43.80% (+2.8M) YoY NEW(+9.3M)	All Managers (Combined)	$67.7M	QoQ +33.69% (+$17.1M) YoY NEW(+$67.7M)
Nurix Therapeutics, Inc.(NRIXcusip67080M103)	5.5M	QoQ +83.33% (+2.5M) YoY +83.46% (+2.5M)	All Managers (Combined)	$65.3M	QoQ +15.60% (+$8.8M) YoY +48.27% (+$21.3M)
Geron Corp(GERNcusip374163103)	38.2M	QoQ +851.72% (+34.2M) YoY +25.14% (-7.7M)	All Managers (Combined)	$60.7M	QoQ +327.46% (+$46.5M) YoY -39.70% (-$40.0M)
Sarepta Therapeutics, Inc.(SRPTcusip803607100)	899.7K	QoQ NEW(+899.7K) YoY NEW(+899.7K)	All Managers (Combined)	$57.4M	QoQ NEW(+$57.4M) YoY NEW(+$57.4M)
Ultragenyx Pharmaceutical Inc.(RAREcusip90400D108)	1.4M	QoQ +106.57% (+696.5K) YoY +704.60% (+1.2M)	All Managers (Combined)	$48.9M	QoQ +77.80% (+$21.4M) YoY +524.00% (+$41.0M)
Ani Pharmaceuticals Inc(ANIPcusip00182C103)	700.0K	QoQ +7.85% (+51.0K) YoY -14.84% (-122.0K)	All Managers (Combined)	$46.9M	QoQ +30.61% (+$11.0M) YoY -17.52% (-$10.0M)